Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

BACKGROUND: To investigate the prognostic value of quality of life (QOL) relative to tumour marker carbohydrate antigen (CA) 19-9, and the role of CA 19-9 in estimating palliation in patients with advanced pancreatic cancer receiving chemotherapy. METHODS: CA 19-9 serum concentration was measured at...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernhard, J, Dietrich, D, Glimelius, B, Hess, V, Bodoky, G, Scheithauer, W, Herrmann, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990612/
https://www.ncbi.nlm.nih.gov/pubmed/20877359
http://dx.doi.org/10.1038/sj.bjc.6605929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990612/
https://www.ncbi.nlm.nih.gov/pubmed/20877359
http://dx.doi.org/10.1038/sj.bjc.6605929

Ejemplares similares